Ingersoll Rand Inc. (IR) · Oct 29, 2026 · Earnings
Beat — Adjusted diluted EPS $1.07 vs ~$0.89 consensus; FY revenue growth raised to 5.5%-7.0%
Ingersoll Rand earnings beat expectations, with strong orders and cash flow driving a sharp 2026 guidance increase. A large ILC Dover recovery boosts reported results.
Ingersoll Rand is a M&A-led industrial compounder built around mission-critical flow-creation, life-science and industrial technologies, with its IRX operating system and free cash flow funding acquisitions and shareholder returns. This filing materially advances that story: demand accelerated, guidance rose, and capital-return capacity expanded.
The quarter beat the market’s bar. Revenue was $2.065 billion versus published expectations of roughly $2.04-$2.05 billion, while adjusted diluted EPS was $1.07 versus consensus near $0.89. The operational signal was stronger than the modest revenue beat: orders rose 20.7% year over year, including 22.1% organic growth in IT&S, and the company cited a roughly $195 million engineered-to-order infrastructure project.
The bigger surprise is the guidance increase. Full-year revenue growth is now expected at 5.5%-7.0%, up from the prior 2.5%-4.5% range, and adjusted EPS is now $3.58-$3.70 versus the prior $3.45-$3.57 range. EBITDA guidance stayed at $2.13-$2.19 billion, so the upgrade is primarily a revenue and earnings-per-share reset rather than a wholesale profitability rethink.
| Metric | Q3 2026 | Q3 2025 | Consensus / prior guide |
|---|---|---|---|
| Revenue (Financial Statements) | $2,064.9M (+5.6%) | $1,955.0M | ~$2,040M-$2,050M |
| Adjusted diluted EPS (Adjusted Net Income) | $1.07 (+24.4%) | $0.86 | ~$0.89 |
| Orders (Segment results) | $2,345.1M (+20.7%) | $1,942.3M | |
| Adjusted EBITDA (Adjusted EBITDA reconciliation) | $584.4M (+7.3%) | $544.6M | |
| Free cash flow (Cash Flow reconciliation) | $623.3M (+91.5%) | $325.5M | |
| FY revenue growth (Guidance Metric) | 5.5%-7.0% | 2.5%-4.5% prior guide | |
| FY adjusted EPS (Guidance Metric) | $3.58-$3.70 | $3.45-$3.57 prior guide |
Core execution improved, but the headline EPS beat is not entirely repeatable. P&ST’s adjusted EBITDA margin excluding tariff refunds rose to 32.6%, up 180 basis points year over year, while IT&S margin fell 120 basis points because of inflation. The quarter also included a $380.1 million recovery of acquisition-related losses, and total ILC Dover-related recoveries reached approximately $425.1 million. That makes the business momentum real, but makes reported adjusted EPS a less clean measure of underlying earnings power.
The balance sheet now supports both M&A and buybacks. Nine-month free cash flow reached $1.056 billion, net debt leverage fell to 1.6x, and the board added $2 billion to the repurchase authorization on top of $313 million remaining. This reinforces IR’s capital-allocation model, although the authorization is flexibility rather than a commitment to spend the full amount.
Bottom line: This is a genuine upgrade to the operating story: demand and orders strengthened enough to lift full-year revenue and EPS guidance. The main qualification is that the quarter’s outsized EPS benefit includes a large ILC Dover recovery, so the guidance raise matters more than the headline earnings beat alone.
Q3 earnings call, October 30, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!